-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hf/ETtezUxOX134Lz69Pj/58hJ634Tdh5jpL6t7FKdgoEhXzFLyHtsU7dvCQkl5Q nfxBjBUezE+dhZ/6C4tDFQ== 0000950172-96-000539.txt : 19960910 0000950172-96-000539.hdr.sgml : 19960910 ACCESSION NUMBER: 0000950172-96-000539 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960909 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INNOVIR LABORATORIES INC CENTRAL INDEX KEY: 0000901099 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133536290 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21972 FILM NUMBER: 96627667 BUSINESS ADDRESS: STREET 1: 510 E 73RD ST CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2122494703 COMPANY DATA: COMPANY CONFORMED NAME: ARIES TRUST CENTRAL INDEX KEY: 0001017537 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128325700 3 1 FORM 3 U.S. SECURITIES AND EXCHANGE COMMISSION _____________________ WASHINGTON, D.C. 20549 | OMB APPROVAL | INITIAL STATEMENT OF |_____________________| BENEFICIAL OWNERSHIP OF SECURITIES |OMB NUMBER: 3235-0104| |EXPIRES: | | SEPTEMBER 30, 1998 | Filed pursuant to Section 16(a) of the |ESTIMATED AVERAGE | Securities Exchange Act of 1934, |BURDEN HOURS | Section 17(a) of the Public Utility |PER RESPONSE 0.5 | Holding Company Act of 1935 |_____________________| or Section 30(f) of the Investment Company Act of 1940 ____________________________________________________________________________ 1. Name and Address of Reporting Person The Aries Trust _________________________________________________________________________ (Last) (First) (Middle) 375 Park Avenue ________________________________________________________________________ (Street) New York N.Y. 10152 _________________________________________________________________________ (City) (State) (Zip) ____________________________________________________________________________ 2. Date of Event Requiring Statement (Month/Day/Year) August 30, 1996 ____________________________________________________________________________ 3. IRS OR SOCIAL SECURITY NUMBER OF REPORTING PERSON (VOLUNTARY) ____________________________________________________________________________ 4. Issuer Name and Ticker or Trading Symbol Innovir Laboratories, Inc. "INVR" ____________________________________________________________________________ 5. RELATIONSHIP OF REPORTING PERSON(S) TO ISSUER (CHECK ALL APPLICABLE) ( ) DIRECTOR (X ) 10% OWNER ( ) OFFICER (GIVE TITLE BELOW) ( ) OTHER (SPECIFY TITLE BELOW) _____________________________________ ____________________________________________________________________________ 6. IF AMENDMENT, DATE OF ORIGINAL (MONTH/DAY/YEAR) N/A ____________________________________________________________________________ 7. INDIVIDUAL OR JOINT/GROUP FILING (CHECK APPLICABLE LINE) X FORM FILED BY ONE REPORTING PERSON ___FORM FILED BY MORE THAN ONE REPORTING PERSON ============================================================================ TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED ____________________________________________________________________________ |1. TITLE OF SECURITY|2. AMOUNT OF |3. OWNERSHIP |4. NATURE OF INDIRECT | | (INSTR. 4) | SECURITIES | FORM DIRECT| BENEFICIAL OWNERSHIP| |Common Stock, par | BENEFICIALLY| DIRECT (D) | (INSTR. 5) | |value, $.013 per | OWNED | OR INDIRECT| | |share | (INSTR. 4) | (I) (INSTR.| | | | 2,800,000+ | 5) | | |____________________|_______________|________Direct|_______________________| ============================================================================ TABLE II.A - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) ____________________________________________________________________________ 1. Title of Derivative Security (Instr. 4) Class C Warrants ____________________________________________________________________________ 2. Date Exercisable and Expiration Date (Month/Day/Year) August 30, 1996 August 30, 2006 Date Exercisable Expiration Date ____________________________________________________________________________ 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) Common Stock, par value $.013 per share 2,800,000++ Title Amount of Number of Shares ____________________________________________________________________________ 4. Conversion or Exercise Price of Derivative Security $.50 per share, subject to certain anti-dilution adjustments ____________________________________________________________________________ 5. Ownership Form of Derivative Security: Direct(D) or Indirect(I)(Instr. 5) Direct ____________________________________________________________________________ 6. Nature of Indirect Beneficial Ownership (Instr. 5) ============================================================================ TABLE II.B - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) ____________________________________________________________________________ 1. Title of Derivative Security (Instr. 4) Unit Purchase Options ____________________________________________________________________________ 2. Date Exercisable and Expiration Date (Month/Day/Year) August 30, 1996 March 1, 1998 Date Exercisable Expiration Date ____________________________________________________________________________ 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) Option to Purchase Units, each Unit 1,400,000 shares of Common consisting of one share of Common Stock, Stock and 1,400,000 Class C par value $.013 per share and one Class Warrants C Warrant ____________________________________________________________________________ 4. Conversion or Exercise Price of Derivative Security $.50 per Unit, subject to certain anti-dilution adjustments ____________________________________________________________________________ 5. Ownership Form of Derivative Security: Direct(D) or Indirect(I)(Instr. 5) Direct ____________________________________________________________________________ 6. Nature of Indirect Beneficial Ownership (Instr. 5) ============================================================================ EXPLANATION OF RESPONSES: Excludes: (i) 2,800,000 shares of Common Stock issuable upon exercise of outstanding Class C Warrants; (ii) 1,400,000 shares of Common Stock issuable upon exercise of outstanding Unit Purchase Options; and (iii) 1,400,000 shares of Common Stock issuable upon exercise of Class C Warrants issuable upon exercise of Unit Purchase Options, as Class C Warrants and Unit Purchase Options are set forth in Table II. Excludes 1,400,000 Class C Warrants issuable upon exercise of Unit Purchase Options, as Unit Purchase Options are set forth in this Table II. The Aries Trust By: Paramount Capital Asset Management, Inc. (f/k/a Aries Financial Services, Inc.) as General Partner /s/ Lindsay A. Rosenwald, M.D. September 9, 1996 ** SIGNATURE OF REPORTING PERSON DATE Name: Lindsay A. Rosenwald, M.D. Title: Chairman of the Board, President _____________________________ ** INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACTS CONSTITUTE FEDERAL CRIMINAL VIOLATIONS. SEE 18 U.S.C. 1001 AND 15 U.S.C. 78FF(A). NOTE: FILE THREE COPIES OF THIS FORM, ONE OF WHICH MUST BE MANUALLY SIGNED. IF SPACE PROVIDED IS INSUFFICIENT, SEE INSTRUCTION 6 FOR PROCEDURE POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOR REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB NUMBER. ============================================================================= -----END PRIVACY-ENHANCED MESSAGE-----